Cargando…
Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
Regadenoson is a selective adenosine 2a (A2a) receptor agonist that is used in cardiac stress testing to evaluate for ischemic heart disease and has largely replaced adenosine in the modern era. Since adenosine receptors are involved in synaptic transmission between neurons throughout the central ne...
Autores principales: | Radwan, Sohab S., Schwartz, Owen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476027/ https://www.ncbi.nlm.nih.gov/pubmed/31089430 http://dx.doi.org/10.1155/2019/6240605 |
Ejemplares similares
-
Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021) -
Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014) -
Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023) -
Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012) -
Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)